MedPath

Cumberland Pharmaceuticals Inc.

Cumberland Pharmaceuticals Inc. logo
🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

1

Active:1
Completed:0

Trial Phases

0 Phases

Drug Approvals

6

FDA:5
NMPA:1

Drug Approvals

Telavancin Hydrochloride for Injection

Product Name
注射用盐酸替拉凡星
Approval Number
国药准字HJ20250017
Approval Date
Feb 11, 2025
NMPA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.